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Boundaries between Chromosomal Domains
of X Inactivation and Escape Bind CTCF and Lack
CpG Methylation during Early Development
10%to20%of humanX-linkedgenes escape inactiva-
tion (Carrel et al., 1999), while only a few mouse genes
are reported to escape (Disteche, 1995; Disteche et al.,
2002). We have shown that, prior to escape, the mouse
Jarid1c (Jumonji, AT-rich interactive domain 1C) gene,
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Seattle, Washington 98109 silenced on the inactive X chromosome of embryos,
2Department of Pathology suggesting that this initial silencing is not effectively
3Department of Medicine maintained, resulting in reactivation in adults (Carrel et
University of Washington al., 1996; Sheardown et al., 1996; Lingenfelter et al.,
Seattle, Washington 98195 1998). In adult tissues, the 5 CpG island of escape
4Children’s Hospital and Regional Medical Center genes is unmethylated (Goodfellow et al., 1988) and
Seattle, Washington 98115 the associated histone code is characteristic of active
chromatin (Gilbert and Sharp, 1999; Boggs et al., 2002).
The existence of adjacent domains of inactive and
active chromatin along the X chromosome (Goldman et
al., 1987) is supported by the findings of clusters ofSummary
escape genes (Miller and Willard, 1998; Tsuchiya and
Willard, 2000). These clusters can differ between mam-Escape from X inactivation results in expression of
malian species: for example, mouse Jarid1c is the onlygenes embedded within inactive chromatin, sug-
gene that escapes within a domain, whereas humangesting the existence of boundary elements between
JARID1C is part of a large escape domain (Tsuchiyadomains.We report that the 5 end of Jarid1c, a mouse
and Willard, 2000; Tsuchiya et al., 2004). The structureescape gene adjacent to an inactivated gene, binds
of escape domains has not been characterized in termsCTCF, displays high levels of histone H3 acetylation,
of potential chromatin boundary elements that may pro-and functions as a CTCF-dependent chromatin insula-
tect them.tor. CpG island methylation at Jarid1c was very low
during development and virtually absent at the CTCF Several well-characterized chromatin insulators con-
sites, signifying that CTCF may influence DNAmethyl- tain binding sites for the 11-zinc finger protein CTCF
ation and chromatinmodifications. CTCF binding sites (Bell et al., 1999; Bell and Felsenfeld, 2000; Hark et al.,
were also present at the 5 end of two other escape 2000; Filippova et al., 2001). CTCF, a widely expressed
genes, mouse Eif2s3x and human EIF2S3, each adja- nuclear protein that binds to diverse DNA sequences
cent to an inactivated gene, but not at genes embed- through usage of different combinations of its individual
ded within large escape domains. Thus, CTCF was zinc fingers, has been implicated in the enhancer-
specifically bound to transition regions, suggesting blocking function of chromatin insulators (Lobanenkov
a role in maintaining both X inactivation and escape et al., 1990; Filippova et al., 1996, 1998; Bell et al., 1999).
domains. Furthermore, theevolutionofXchromosome CTCF binds DNA in amethylation-sensitivemanner (Bell
domains appears to be associated with repositioning and Felsenfeld, 2000; Hark et al., 2000; Filippova et al.,
of chromatin boundary elements. 2001) andplays a role in themaintenance ofmethylation-
free zones of imprinting control regions (Pant et al., 2003;
Schoenherr et al., 2003; Fedoriw et al., 2004; Szabo etIntroduction
al., 2004).
Here, we report that CTCF binding sites are presentA number of genes on the mammalian X chromosome
at the 5 ends of mouse Jarid1c and Eif2s3x (eukaryoticescape X inactivation (Disteche et al., 2002; Brown and
translation initiation factor 2 subunit 3 ) and of humanGreally, 2003). Little is known of the mechanisms that
EIF2S3; each of these genes escapes X inactivation andprotect escape genes from silencing. X inactivation is
is adjacent to a gene subject to X inactivation. Their 5achieved through a series of steps initiated during fe-
end is also associated with a high level of histone H3male development (Avner and Heard, 2001; Plath et al.,
acetylation. In contrast, no CTCF binding sites are pres-2002). Genes on the inactive X chromosome undergo
ent at the 5 end of two other escape genes, humansequential epigenetic modifications, including histone
JARID1C and KIAA0522, each adjacent to another es-modifications, chromatin condensation, and late repli-
cape gene. Furthermore, mouse Jarid1c 5 CpG islandcation (Plath et al., 2002). DNA methylation at the 5
functions as aCTCF-dependent chromatin insulator andCpG islands appears to be a late event not required for
initiation and propagation of X inactivation (Sado et al., displays very low DNAmethylation during development,
2004) but necessary for its stable maintenance (Hansen with virtually none at the CTCF binding sites. These
et al., 2000; Sado et al., 2000). findings suggest that CTCF may prevent the propaga-
tion of DNAmethylation and associated chromatinmod-
ifications within escape domains, resulting in failure to*Correspondence: gfilippo@fhcrc.org (G.N.F), cdistech@u.washington.
edu (C.M.D.) maintain stable silencing.
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Figure 1. Identification of CTCF Binding Sites at the 5 End of Mouse Jarid1c but Not at Human JARID1C
(A) Mouse Jarid1c region indicating the inactivation status of genes (blue, subject to X inactivation; yellow, escapes X inactivation), the CpG
islands (red), the DNA fragments for gel shift assays, and the region conserved between human and mouse (conserved). Gel shift assays
using the 11-zinc finger domain of CTCF () or lysate control () are shown under the map. A gel shift was observed for Jarid1c fragments
1, 3, and 5, corresponding to CTCF binding sites 3, 2, and 1, respectively. No gel shift was observed for Kiaa0522. Control positive gel shifts
were obtained for the known CTCF binding region of the chicken -globin gene (FII).
(B) Human JARID1C region. Same analysis as in (A). There was no evidence of CTCF binding sites at JARID1C and KIAA0522.
Results larger escape domain in human (Schneider-Gadicke et
al., 1989; Adler et al., 1991; Ashworth et al., 1991).
Eif2s3x/EIF2S3 have a dense CpG island and encodeEscape Domains Differ between Mouse
and Human translation initiation and elongation factors (http://www.
ncbi.nlm.nih.gov). We determined that 6330500C13Rik,The 5 end of Jarid1c, a mouse gene known to escape
X inactivation, is locatedabout 7 kbaway fromKiaa0522, located about 22 kb upstreamofEif2s3x, andAK057298,
about 28 kb upstream of EIF2S3, were both subject toa gene subject to X inactivation (Figure 1A; Tsuchiya et
al., 2004). The overall genomic organization of these X inactivation (Supplemental Figure S1 at http://www.
developmentalcell.com/cgi/content/full/8/1/31/DC1/).genes is conserved in human, but both human JARID1C
and KIAA0522 escape X inactivation within a domain Thus, like mouse Jarid1c, both mouse Eif2s3x and hu-
man EIF2S3 have their 5 end located in a transitionthat spans about 285 kb and contains six apparently
independent transcripts (Figure 1B; Tsuchiya et al., region between escape and inactivated domains (Fig-
ures 2A and 2B).2004). Sequence comparison of the 5 ends of the
Jarid1c/JARID1C genes revealed regions of high homol-
ogy (77% identity), located up to nt 375 relative to
the transcription start site (data not shown). Jarid1c/ CTCF Binding Sites Are Located within the 5 CpG
Islands of Escape Genes AdjacentJARID1C have a dense CpG island and are predicted
to encode for transcription factors (http://www.ncbi. to Inactivated Domains
Gel mobility shift assays to search for CTCF bindingnlm.nih.gov). Previous studies using luciferase assays
indicate that Jarid1c promoter is TATA-less and in- sites at the 5 end of mouse Jarid1c were done using
overlapping PCR-amplified DNA fragments that span-cluded in a 2.3 kb region upstream from the transcription
start site (Tsuchiya and Willard, 2000). ned about 1300 bpwithin the CpG island, and the in vitro
translated DNA binding domain of CTCF (CTCF 11ZF),Another set of domains that differ between mouse
and human contain the escape genes Eif2s3x/EIF2S3 which has the same sequence specificity as the full-
length protein (Figure 1A; Vostrov and Quitschke, 1997).(Ehrmann et al., 1998). At the 3 end ofmouseEif2s3x lies
Zfx (zinc finger on the X chromosome), a gene subject to Three fragments interacted with CTCF: fragments 5 (site
1) and 3 (site 2) showed the strongest interaction,X inactivation, whereas ZFX escapes, resulting in a
CTCF between Domains of X Inactivation and Escape
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Figure 2. Identification of CTCF Binding
Sites at the 5 Ends of Mouse Eif2s3x and
Human EIF2S3
(A)Mouse Eif2s3x region indicating the inacti-
vation status of genes (blue, subject to X inac-
tivation; yellow, escapes X inactivation), the
CpG islands (red), and the DNA fragments
used for gel shift assays. Gel shift assays
using the 11-zinc finger domain of CTCF ()
or lysate control () are shown under the
map. Gel shifts were observed for fragments
8 (site 1) and 5 (site 2). Control positive gel
shifts were obtained for the known CTCF
binding region of the chicken -globin gene
(FII).
(B) Human EIF2S3 region. Same analysis as
in (A). Gel shift were observed for fragments
5 (site 1) and 4 (site 2).
whereas fragment 1 (site 3) was weaker and was not shown). A similar analysis was done for Eif2s3x and
EIF2S3, confirming specific CTCF binding to their 5 endcharacterized further (Figure 1A).
Regions of high DNA sequence similarity between (Figures 3B and 3C).
Footprinting analysis was used to delineate the CTCFmouse and human Jarid1c/JARID1C overlapped the
three CTCF sites found in mouse (Supplemental Figure binding sites within the DNA fragments positive for a gel
mobility shift. CTCF protected from DNase I digestionS2A). However, an important difference between the
species is that Jarid1c is flanked at its 5 end by about 50 bp on both strands at each Jarid1c site, and
methylation interference assays identified “contact”Kiaa0522 and Smc1l1, both subject to X inactivation,
while JARID1C, KIAA0522, and SMC1L1 all escape X guanines whose methylation prevented or reduced
CTCF binding (Figure 3A). Jarid1c sites 1, 2, and 3 wereinactivation, raising the question of the functional con-
servation of CTCF binding sites in human. Interestingly, mapped relative to the transcription start site to nt376
to 320, nt 111 to 55, and approximately nt 160 tono interaction between CTCF and the 5 end of human
JARID1C was found (Figure 1B). Similarly, there was no 215, respectively. Each site had 2–3 CpG dinucleotides
containing contact guanines. Several contact guaninesevidence of CTCF binding at the 5CpG islands of either
Kiaa0522 or KIAA0522 (Figures 1A and 1B). were not preserved in the corresponding human JARID1C
sequence, which may explain the lack of CTCF bindingTo determine whether CTCF binding sites were pres-
ent at the 5 end of other genes located within a transi- (Supplemental Figure S2A). DNA methylation abolished
CTCF binding, as shown by gel mobility shift assays ontion region betweendomains of escape and inactivation,
we examined mouse Eif2s3x and human EIF2S3. Gel in vitro methylated DNA (Supplemental Figure S3 and
data not shown). DNase I footprinting and methylationmobility shift assays revealed two strong CTCF binding
sites at the 5 CpG islands of both Eif2s3x (fragment 8 interference assays (Supplemental Figure S4) were done
to map Eif2s3x sites to nt 1090 to 1138 (site 1) and[site 1] and fragment 5 [site 2]) and EIF2S3 (fragment 5
[site 1] and fragment 4 [site 2]) (Figures 2A and 2B). nt 563 to 614 (site 2) and EIF2S3 sites to nt 645 to
697 (site 1) and nt 514 to 565 (site 2), respectivelyTaken together, our data indicate that CTCF binding
sites are not simply associated with genes that escape (Figures 3B and 3C). The sequence of CTCF site 2, but
not site 1, was partially conserved between speciesbut appear tobe specifically locatedat transition regions
between domains. (Supplemental Figure S2A).
Aside from the presence of clusters of contact gua-
nines, comparison of Jarid1c, Eif2s3x, and EIF2S3 bind-Characterization of CTCF Binding Sites
To confirm specific binding of CTCF to Jarid1c 5 CpG ing sites showed no evidence of a single consensus
sequence and little similarity to previously publishedisland, we used gel mobility shift assays with the in vitro
translated full-length protein (in vitro CTCF) and with CTCF sites (Supplemental Figures S2B and S2C).
nuclear extracts from several cell types, including
mouse CB3, human K562, and primary human fibro- In Vivo Binding of CTCF in Transition Regions
Chromatin immunoprecipitation (ChIP) using a mono-blasts. Specificity of CTCF binding was established us-
ing antibodies and competitors (Figure 3A and data not clonal antibody against CTCF was done on chromatin
Developmental Cell
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Figure 3. Characterization of the CTCF Binding Sites
(A) Mouse Jarid1c CTCF sites. Upper left: Gel shift assays of site 1 show specific interactions with both in vitro translated and endogenous
CTCF (nuclear extracts). Addition of either anti-CTCF antibody (-CTCF AB) or a competitor containing known CTCF sites from the chicken
-globin (FII) or H19 loci abolished the gel shift. Nonspecific competitor (ns competitor) or antibody (ns AB) did not affect binding. fl, full-
length protein; 11ZF, DNA binding domain; arrows, shifted protein-DNA complexes. Right: DNase I footprinting and methylation interference
(DMS) analyses of sites 1 and 2. Top and bottom strand indicate strand end-labeled with 32P. Lane B, CTCF bound DNA probes; lane F, free
DNA probes; lane G, Maxam-Gilbert sequencing G ladder; horizontal bars, guanines essential for CTCF recognition; vertical bars, regions
protected from DNase I digestion; arrows, DNase I-hypersensitive sites induced by CTCF binding. Bottom left: Sequence of sites 1 and 2.
Vertical bars, contact guanines; horizontal bars, regions protected from DNase I digestion; arrows, DNase I hypersensitive sites; underlined,
CpG dinucleotides; Site1mut, mutation disrupting CTCF site 1; Site2mut, mutation disrupting CTCF site 2.
(B) Mouse Eif2s3x CTCF sites. Top: Gel shift assays of sites 1 and 2. Same analysis as in (A) upper left. NE, nuclear extracts. Bottom: Sequence
of sites 1 and 2 (same annotation as in [A]), as determined by DNase I footprinting and methylation interference analyses (Supplemental
Figure S4).
(C) Human EIF2S3 CTCF sites. Same analysis as in (B).
CTCF between Domains of X Inactivation and Escape
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Figure 4. In Vivo CTCF Binding and Histone H3 Acetylation Analyses by ChIP
(A) ChIP for the 5 ends of mouse Jarid1c, Kiaa0522, Eif2s3x, Pgk1, and Rbmx using a CTCF antibody and of Jarid1c and Eif2s3x using an
acetylated histone H3 (AceH3) antibody. PCR amplifications of fractions obtained in the absence of antibody (No Ab), in the presence of
antibody (CTCF; AceH3), and of the input fraction (IF) are shown for Patski cells, except for Jarid1c, also shown for Hobmski cells. Control
PCR amplifications of decreasing amounts of IF demonstrate decreased band intensity. Jarid1c and Eif2s3x and the control H19 gene, but
not the other genes, show enrichment in the CTCF antibody lane; Jarid1c and Eif2s3x also show enrichment in the AceH3 lane. Xa, active X
allele; Xi, inactive X allele.
(B) ChIP for the 5 ends of human JARID1C, KIAA0522, EIF2S3 in hybrid cell lines that retains either an inactive X (Xi) or an active X (Xa). PCR
amplifications show enrichment in the CTCF antibody lane (CTCF), compared to the no-antibody lane (No Ab) for EIF2S3, but not for JARID1C
and KIAA0522. EIF2S3 also shows enrichment in the acetylated histone H3 antibody lane (AceH3).
(C) Relative enrichment (as a fraction of the highest enrichment for each antibody) for CTCF (dotted line) and acetylated histone H3 (solid
line) in the Jarid1c region for Patski (Pat) and Hobmski (Hob) cell lines. PCR assays were done at nt 2500, nt 350 (gel shown in [A]),
nt 200, and nt 2000, from the transcription start site (arrow). Each point represents average enrichment (standard error) in the antibody
fractions. The position of CTCF sites is indicated.
prepared from mouse cell lines with skewed X inactiva- than that to the active X (Xa), after correcting for the
ratios found in the input fraction (Figure 4A). Similarly,tion of either the M. spretus X (Hobmski) or the C57BL/
6J X chromosome (Patski) (Bressler et al., 1993; Lingen- a higher enrichment for the 5 end of human EIF2S3was
observed for the human inactive X (Xi) versus the activefelter et al., 1998) and from two hybrid cell lines retaining
the human X chromosome, either active or inactive one (Xa) (Figure 4B). However, the apparently stronger
CTCF binding to the inactive X may result from different(Lingenfelter et al., 2001). PCR analysis showed enrich-
ment of the products corresponding to the 5 ends of efficiency of DNA/protein cross-linking and/or antibody
binding due to different chromatin conformation be-mouse Jarid1c and Eif2s3x and human EIF2S3 in the
CTCF ChIP fractions, confirming our in vitro results (Fig- tween the X chromosomes.
Taken together, our data indicated that CTCF wasures 4A and 4B). Jarid1c alleles were distinguished by
a size polymorphism (10 bp insertion upstream of CTCF bound in vivo to the 5 ends of mouse Jarid1c and
Eif2s3x and of human EIF2S3. PCR amplifications of thesite 1) in C57BL6/J, as compared to M. spretus. CTCF
binding to the inactive X (Xi) appeared to be stronger 5 ends of mouse Kiaa0522 and human JARID1C and
Developmental Cell
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KIAA0522 showed no enrichment in the CTCF antibody DNA Methylation at Jarid1c CpG Island Is Very
Low in Embryos and Consistently Absentfraction, as predicted (Figures 4A and 4B). To further
from CTCF Binding Sitesrule out that the presence of CTCF binding sites was
Our previous studies have shown that escape of Jarid1csimply a common finding amongCpG islands of X-linked
from X inactivation is preceded by silencing during de-genes, ChIP was done on two additional genes subject
velopment (Lingenfelter et al., 1998). Silencing byX inac-to X inactivation, Pgk1 (phosphoglycerate kinase 1) and
tivation is usually accompanied by methylation of theRbmx (RNA binding motif protein, X chromosome). Al-
CpG island (Plath et al., 2002). To determine whetherthough these genes possess CpG islands, there was no
Jarid1c inactivation and reactivation were associatedevidence of in vivo CTCF binding (Figure 4A).
with methylation changes during development, bisulfite
sequencing was done for a region containing a total ofMouse Jarid1c 5 End Is Associated with a Peak
53CpGsites fromnt570 to 281. Little or nomethylationin Acetylated Histone H3 and Functions
was found at any CpG sites. From embryonic to adultas an Insulator
stages, male and female mice showed 90%–100% ofChIP using an antibody against acetylated histone H3
molecules being unmethylated at the majority of CpGshowed a peak of enrichment at Jarid1c, around the
sites (Figure 6). A single CpG site 24, which displayedCTCF sites (Figures 4A and 4C). The presence of a peak
slightly higher DNA methylation in 7.5 dpc female em-in histone H3 acetylation at Jarid1c 5 end is consistent
bryos as compared to male embryos (13% moleculeswith its role as a chromatin insulator element (West et
methylated), became rapidly unmethylated at lateral., 2002). Enrichment in acetylated histone H3 was also
stages.found at the 5 ends of Eif2s3x and EIF2S3 (Figures 4A
Taken together, our data indicated that DNA methyla-and 4B).
tion was generally very low at the 5 end of Jarid1c andTo determine whether the 5 end of Jarid1c could
that the partial DNA methylation observed at the singlecontribute insulator activity, we compared the en-
site 24 in early female embryos was rapidly lost duringhancer-blocking activity of this region to the well-known
development. In both embryos and adult tissues, ourinsulator HS4 (hypersensitive site 4 from the chicken
analyses showed that DNA methylation was virtually-globin locus), using constructs described previously
absent from CpG sites 19–21, 31–33, and 43–47 located(Bell et al., 1999; Bell and Felsenfeld, 2000; Hark et al.,
within CTCF binding sites 1, 2, and 3, respectively (Fig-2000; Filippova et al., 2001). In this system, sequences
ure 6).inserted between an enhancer and the neomycin gene
are assayed for a potential reduction in the number of
DiscussionG418-resistant colonies after transfection of constructs.
Insertion of the mouse Jarid1c region containing CTCF
Chromatin insulators protect domains of the genomebinding sites 1 and 2 (nt 682 to 25), but not of the
from being activated or silenced due to either inappro-corresponding human JARID1C region (nt687 to25),
priate action of outside enhancers/silencers or proximitysignificantly reduced the number of colonies obtained,
to inactive condensed chromatin. In the context of Xcompared to the parent vector (Figure 5A). The insula-
inactivation, such insulators could helpmaintain expres-
tion provided by Jarid1c was about half as efficient as
sion of specific genes within domains on the inactive X
that of the HS4 insulator and appeared to be indepen-
chromosome, either by protecting escape genes from
dent of insert orientation. Moreover, the insulator func- silencing or by protecting inactivated genes from activa-
tion of Jarid1c CpG island was absolutely dependent tion. To our knowledge, this is the first report on the
on CTCF binding: mutations within the recognition core characterization of boundary elements between adja-
sequence of both sites 1 and 2 (Figure 3C) eliminated cent domains of inactive and active chromatin along the
binding (data not shown) and resulted in almost com- inactive X chromosome. We have determined that the
plete loss of insulator activity (Figure 5A). chromatin insulator protein CTCF binds to the 5 end of
To assay the 5 end of Jarid1c for potential repressor three genes, mouse Jarid1c and Eif2s3x and human
activity and/or insulation from position effect, we in- EIF2S3, all three located in transition regions between
serted it upstream of the neo gene-enhancer cassette domains. In contrast, other genes, either subject to X
in place of the HS4 insulator (Figure 5B). Comparison inactivation or escape genes not at a transition region,
of constructs, including mouse Jarid1c, the mutated did not show association with CTCF. In particular, we
Jarid1c, and the human JARID1C to the HS4 and the have demonstrated that CTCF binding sites are absent
insulator-less constructs, showed no decrease in the at human JARID1C, which, in contrast to the mouse
number of G418-resistant colonies for the 5 end of gene, is part of a large escape domain (Tsuchiya and
mouse Jarid1c, which, like the HS4 insulator, did not Willard, 2000; Tsuchiya et al., 2004). CTCF binding sites
have inhibitory effect on the neomycin gene (Figure 5B). at the 5 end of mouse Jarid1c could elicit an insulator
In fact, there was a significant increase in the number activity in enhancer blocking and protection from posi-
of G418-resistant colonies specifically for Jarid1c in- tion effects assays, but the corresponding region in hu-
serted in the 5-3 orientation, indicating that this region man JARID1C could not. These findings suggest that
increased the likelihood that the reporter gene remained escape is probably not regulatedat the level of individual
expressed at random genomic sites and suggesting po- genes, but rather at the level of the chromatin domains.
tential insulation from position effects. Finally, we have shown that CpGmethylation is very low
Taken together, these data indicate that the CTCF at Jarid1c 5 end throughout development, suggesting
binding sites at the 5 end of Jarid1c play a role in the that CTCFmay interfere with the establishment of meth-
ylation.insulator activity of this region.
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Figure 5. Insulator Activity of the Mouse Jarid1c 5 End Dependent on CTCF Binding
(A) Enhancer-blocking assays: mouse Jarid1c CpG island, the same with mutated CTCF sites (Figure 3A), human JARID1C CpG island, and
a control known insulator (HS4 from the chicken -globin gene) were cloned into the pJC vector at the SacI site between the HS2 enhancer
and the neo gene driven by the -globin promoter, with an adjacent insulator element HS4 from the chicken -globin gene. Colony assays
of K562 cells selected in G418 (histogram below) demonstrate that mouse Jarid1c 5 end (pJC-Jarid) but not human JARID1C functions as
an insulator. Mutation of both Jarid1c CTCF sites (pJC-Jarid-mut) almost completely eliminates insulator activity. Fragments were tested in
forward (5-3) and in reverse (3-5) orientations. pJC-Jarid resulted in a reduction to about 40% (3-5) to 50% (5-3) colonies, compared to
the pJC vector. The positive control pJC-HS4 containing the chicken HS4 insulator showed a reduction to about 30% colonies. Results shown
as an average (with standard error) of at least six independent transfections performed in triplicate.
(B) Repressor activity and protection from position effects assays: the same fragments described above (A) were cloned outside the promoter-
enhancer cassette of the pJCX vector at the XbaI site. Colony assays of K562 cells selected in G418 (histogram below) demonstrate that
mouse Jarid1c 5 end (pJCX-Jarid) does not have repressor activity on the neo gene promoter and provides potential protection from position
effects, especially in the 5-3 orientation. pJCX-Jarid (5-3) resulted in an approximately 80% increase in the number of colonies, compared
to the control pJCX vector. This was the case neither for the human JARID1C construct (pJCX-JARID) nor for the construct with mutated
CTCF sites (pJCX-Jarid-mut). The positive control pJCX-HS4 containing the chicken HS4 insulator showed a 20% increase in colonies. Results
shown as an average (with standard error) of at least four independent transfections performed in triplicate.
Several well-characterized chromatin insulators con- it can block the spreading of repressive telomeric chro-
matin (Defossez and Gilson, 2002). A recent study sug-tainCTCF binding sites (Bell et al., 1999; Bell and Felsen-
feld, 2000; Hark et al., 2000; Filippova et al., 2001;Magdi- gests that the chromatin insulator activity of CTCF may
be mediated by the formation of loops tethered to thenier et al., 2004) and are often associated with a peak
of acetylation at histone H3 (Litt et al., 2001), as we have nucleolus through nucleophosmin binding (Yusufzai et
al., 2004). Moreover, dimerization may mediate interac-observed for Jarid1c and Eif2s3x/EIF2S3. CTCF binding
sites sensitive to DNA methylation have also been lo- tions between CTCF-DNA complexes that could provide
anchor points for the formation of chromatin loops (Pantcated within the imprinting control region of the H19/
Igf2 locus (Bell and Felsenfeld, 2000; Hark et al., 2000) et al., 2004). In the case of the X chromosome, inacti-
vated and escape domains could be located in separateand near the 3 end of Xist, where they may play a role
in X inactivation choice (Chao et al., 2002). In the case chromatin loops, potentially anchored by CTCF and
other insulator elements. Our preliminary analysis of theof the HS4 -globin gene insulator, CTCF has been spe-
cifically implicated in the enhancer-blocking activity of region located3 tomouse Jarid1c showed thepresence
of CTCF binding sites at a CpG island positioned at thethe insulator but not in protection from position effect
(Recillas-Targa et al., 2002). However, CTCF can provide 3 end ofDXBwg1396e, a gene subject to X inactivation,
which mapped about 63 kb from the 3 end of Jarid1c.protection from position effect in a yeast assay, where
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Figure 6. DNA Methylation at the 5 CpG Is-
land of Jarid1c in Embryos and Adult Tissues
DNAmethylation was assayed by bisulfite se-
quencing at 53 CpG sites (x axis of histo-
grams) covering the CpG island of Jarid1c
from nt 570 to the beginning of the coding
sequencewithin exon 1 (nt 289) and including
the CTCF binding sites. The percent of meth-
ylated CpG sites (y axis of histograms) is
shown for 7.5 dpc embryos (65 clones from 4
males and 79 clones from4 females), 8.5–12.5
dpc embryos (42 clones from 7 males and 59
clones from 10 females), and adult tissues (30
clones from 3 males and 24 clones from 3
females). Embryos and tissues from males
are in white and females are in black. CTCF
binding sites 1, 2, and 3 remain essentially un-
methylated.
This suggests the presence of a potential boundary on as we have shown, the 5 end of Jarid1c does not func-
tion as a repressor; and (2) despite the difference inthe other side of Jarid1c, which could mediate the for-
mation of a chromatin loop (Supplemental Figure S5A). CTCF binding at their 5 end, mouse Jarid1c and human
JARID1C are highly conserved and show similar expres-X chromosome-wide screening for CTCF binding sites
will help further delineate chromatin domains. Others sion patterns (Agulnik et al., 1994; Wu et al., 1994a,
1994b).andwehaveobserveda focusofCTCFantibody staining
within the Barr body (Supplemental Figure S5B; Chad- While the CTCF binding sites that we have character-
ized display some similarity to previously reported siteswick andWillard, 2003). It will be interesting to determine
whether the binding sites we have identified here local- based on the presence of a GC-rich core sequence, we
could not derive a definitive consensus sequence. Theize to this focal region.
CTCF is also known as a transcription repressor or presence of additional contact guanines outside of the
previously defined core sequence suggests that thisactivator of some genes (Filippova et al., 1996; Vostrov
and Quitschke, 1997). It could be argued that CTCF core is not sufficient for binding. Furthermore, CTCF
does not bind to the 5 end of human JARID1C, despitedirectly regulates Jarid1c and/orEif2s3x/EIF2S3expres-
sion. However, our findings of CTCF sites at these three the DNA sequence similarity between mouse and hu-
man. This confirms the difficulty in predicting bindingdifferent genetic loci, all located at transitions regions
between domains of inactivation and escape, suggest sites based on DNA sequence analysis alone and re-
flects the ability of CTCF to bind diverse DNA sequencesa common function for these sites in insulating domains.
Additional evidence against a role for CTCF as a tran- by different combinations of its individual zinc fingers
(Filippova et al., 1996). CTCF binding sites tend to bescription factor for all three escape genes includes: (1)
CTCF between Domains of X Inactivation and Escape
39
Figure 7. Model for the Role of CTCF Binding and DNA Methylation in a Hypothetical Domain of Escape from X Inactivation
(A) Prior to X inactivation in embryos, both a gene that escapes and a gene that will become stably inactivated are expressed (yellow). At the
5 end of the genes, the histone code is presumably characteristic of active chromatin (orange) and the CpG island is presumably unmethylated
(white dots). Following initiation and spreading of X inactivation, early histone modifications (green) would take place and genes on the inactive
X become silenced (blue). At a later stage (maintenance), genes that become stably inactivated undergo additional changes including DNA
methylation (black dots) at their CpG island and further histone modifications (purple). However, escape genes would be protected from the
propagation and establishment of these latter changes by the presence of chromatin insulator elements such as CTCF, located at transition
regions between escape and inactivated domains. Lack of DNAmethylation and associated chromatinmodifications would result in progressive
reactivation and escape.
(B) CTCF binding at both ends of an escape domain may isolate such domains within a separate chromatin loop.
found in clusters, suggesting cooperative interactions and no YY1 sites were predicted at the 5 ends of
Eif2s3x/EIF2S3.(Pant et al., 2004). We have found three adjacent sites
at the 5 end of Jarid1c and two at the 5 end of Eif2s3x In the context of X inactivation, which is associated
with CpG island methylation, a role for CTCF in escapeand of EIF2S3. In the case of Jarid1c, site 3 has a low-
affinity binding to CTCF; such a site may still play an suggests potential interference with this methylation
process. CTCF binding to a specific DNA sequence isimportant role in chromatin insulation by cooperation
with the stronger sites, as shown by mutation of a weak closely linked to CpG methylation, with binding both
depending on and regulating methylation. CTCF playssite at the Igf2/H19 cluster (Pant et al., 2004).
In addition to CTCF, other elements are most likely a critical role in the maintenance of the methylation-free
status of the maternal imprinting control region of theneeded to mediate the insulation of chromatin domains
(Ohlsson et al., 2001; Hori et al., 2002; West et al., 2002). Igf2/H19 locus (Pant et al., 2003, 2004; Schoenherr et
al., 2003; Fedoriw et al., 2004; Szabo et al., 2004). WhileSuch elements include matrix attachment regions
(MARs) (Mirkovitch et al., 1984). However, a reporter initiation and propagation of X inactivation take place
in the absence of DNA methylation (Sado et al., 2004),transgene construct flanked by MARs and inserted on
the X chromosome was not protected from the spread- CpG island methylation occurs later and is necessary
for themaintenanceof stable silencing. Indeed, reactiva-ing of X inactivation and the establishment of CpGmeth-
ylation (Chong et al., 2002). In the case of Jarid1c and tion of X-linked genes is prevalent in DNA methyltrans-
ferase mutants such as patients with ICF syndromeEif2s3x/EIF2S3, additional chromatin boundary ele-
ments may be located elsewhere within the genes and/or (immunodeficiency, centromeric instability, and facial
abnormalities) causedbymutations inDNMT3B (Hansenat their 5 or 3 end. Several Sp1 consensus binding sites
have been previously reported at Jarid1c CpG island et al., 2000) and mice deficient in Dnmt1 (Sado et al.,
2000).(Tsuchiya and Willard, 2000). Using the Match program
(http://www.generegulation.de), we have also identified Our current study reports the detailed analysis of CpG
island methylation changes in an escape gene duringa potential binding site for the YY1 transcription factor,
downstream from CTCF site 2 and very close to Jarid1c development. Previous studies have shown that escape
genes lack CpG island methylation in adult tissuestranscription start. YY1 canplay the dual role of a repres-
sor/activator (Weill et al., 2003) andmay also be involved (Goodfellow et al., 1988; Jegalian and Page, 1998). DNA
methylation at Jarid1c CpG island was very low fromin chromatin insulation (Kimet al., 2003). However, unlike
the CTCF binding sites reported here to be specifically 7.5 dpc onward and thus cannot account for the initial
silencing of the gene (Lingenfelter et al., 1998). DNAassociated with mouse Jarid1c, the potential YY1 bind-
ing sitewasalsopresent at the 5endof human JARID1C methylation at Jarid1c may actually be inhibited during
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CpG methylation analyses was done as described (Filippova et al.,development, as outlined in our model (Figure 7A). Fol-
2001). Primers are listed in Supplemental Table S1.lowing this model, insulation of escape genes from adja-
cent inactive chromatin could be mediated by interac-
Chromatin Immunoprecipitation
tions between CTCF and the establishment and/or Chromatin immunoprecipitation (ChIP) was done following amethod
cooperative spreading of DNA methylation (Figure 7A). previously described (Litt et al., 2001). After formaldehyde treatment
This is supported by the near-complete absence of to cross-link DNA and proteins, immunoprecipitation reactions were
set up using sonicated chromatin (200 bp to 1 kb size range) andmethylation at the CpG dinucleotides contained within
antibodies against CTCF (monoclonal antibody, BD TransductionJarid1c CTCF binding sites even during development.
Laboratories) and acetylated histone H3 (multiple acetylated resi-In human, JARID1C CpG island is also unmethylated
dues, Upstate Biotechnology). PCR (30 cycles) wasdone usingprim-
(Jegalian and Page, 1998), and yet CTCF does not bind ers listed in Supplemental Table S1. A minimum of 2–3 ChIP experi-
to this gene, suggesting that protection from methyla- ments was done for each antibody. PCR products were examined
tion and stable silencing results from CTCF binding to by polyacrylamide gel electrophoresis and products quantified by
phospho-imaging or real-time PCR. Data for the ChIP fractions weretransition regions between domains, and not to individ-
normalized to the no-antibody fractions.ual escape genes. Presence of both 5 and 3 boundary
elements flanking an escape domain may mediate the
Insulator Assays
formation of a chromatin loop positioning escape genes pJC-Jarid and pJC-JARIDwere derived by replacing the HS4 insula-
in a separate nuclear compartment (Figure 7B). tor at the SacI site by a 700 bp fragment (in both orientations)
In addition to remaining unmethylated at their CpG from the 5 end of mouse Jarid1c (containing CTCF sites 1 and 2)
and human JARID1C, respectively. pJCX-Jarid and pJCX-JARIDisland, escape genes also lack histone modifications
were obtained by replacing the HS4 insulator at the XbaI site of thethat characterize stably silenced genes (Gilbert and
pJC-HS4 plasmid with the same fragments. Primers used to deriveSharp, 1999; Boggs et al., 2002). Escape genes may be
the fragments are listed in Supplemental Table S1. To generate pJC-
marked in embryogenesis by histone modifications that Jarid-mut, we mutated both CTCF sites 1 and 2 using QuikChange
differ from those of genes destined to be silenced Multi Site-Directed Mutagenesis protocol (Stratagene) and oligonu-
(Rougeulle et al., 2003). It will be important to follow cleotides listed in Supplemental Table S1. Sequencing was done to
confirm identity of the clones. K562 cells were transfected with eachhistone modifications in escape genes during develop-
linearized construct by electroporation and colonies that grew inment. Jarid1c initial and unstable silencing could be due
G418 were counted as described (Filippova et al., 2001).to early chromatin modifications without DNA methyla-
tion, leading to progressive reactivation of the gene dur- DNA Methylation Assays
ing development (Figure 7A). Bisulfite treatment of genomic DNA was done essentially as de-
It is interesting that the size of escape domains differs scribed (Tremblay et al., 1997). PCR and nested PCR were done
using primers designed to include cytosine (in the original sequence)between human and mouse, which may be associated
but no CpG dinucleotides (Supplemental Table S1). PCR productswith repositioning of chromatin boundary elements that
cloned in a TopoTA vector (24 to 79 individual DNA clones per stage)protect domains. In addition to insulating escape genes
were sequenced using the Sequencing Facility in the Department
from silencing by X inactivation, insulator elements of Biochemistry (University of Washington).
could possibly protect inactivated genes from reactiva- Control samples treated with Sss1, which methylates cytosines
tion due to their proximity to escape domains. CTCF within CpG, showed methylation at all sites. 50:50 mixtures of Sss1-
treated and -untreated DNA samples resulted in about half the DNAhas been shown to protect genes from being turned on
clones methylated (data not shown).by nearby enhancer elements (Bell et al., 1999; West et
al., 2002; Zhao and Dean, 2004). In that case, the ab-
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